Home

MaxCyte, Inc. - Common Stock (MXCT)

4.6200
+0.1200 (2.67%)

Maxcyte Inc is a biotechnology company focused on developing and commercializing innovative cell-based therapies and drug discovery solutions

The company specializes in providing its proprietary cell-engineering platform, which enables the rapid development and manufacturing of complex, cell-based therapeutics. By facilitating the delivery of genetic material into various types of cells, Maxcyte aims to enhance the capabilities of researchers and developers in the biopharmaceutical industry, ultimately contributing to the advancement of new treatments for a variety of diseases, including cancer and genetic disorders.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is MaxCyte, Inc. - Common Stock publicly traded?
Yes, MaxCyte, Inc. - Common Stock is publicly traded.
What exchange does MaxCyte, Inc. - Common Stock trade on?
MaxCyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MaxCyte, Inc. - Common Stock?
The ticker symbol for MaxCyte, Inc. - Common Stock is MXCT on the Nasdaq Stock Market
What is the current price of MaxCyte, Inc. - Common Stock?
The current price of MaxCyte, Inc. - Common Stock is 4.620
When was MaxCyte, Inc. - Common Stock last traded?
The last trade of MaxCyte, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025